The Current Ratio as of December 2024 (TTM) for Lisata Therapeutics, Inc. (LSTA) is 8.03

According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.03. This represents a change of -6.99% compared to the average of 8.64 of the last 4 quarters.

Lisata Therapeutics, Inc. (LSTA) Historical Current Ratio (quarterly & annually)

How has LSTA Current Ratio performed in the past?

The mean historical Current Ratio of Lisata Therapeutics, Inc. over the last ten years is 7.44. The current 8.03 Current Ratio has changed 10.69% with respect to the historical average. Over the past ten years (40 quarters), LSTA's Current Ratio was at its highest in in the March 2022 quarter at 32.38. The Current Ratio was at its lowest in in the March 2017 quarter at 0.94.

Lisata Therapeutics, Inc. (LSTA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lisata Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lisata Therapeutics, Inc. (LSTA) Average Current Ratio

How has LSTA Current Ratio performed in the past?

The current Current Ratio of Lisata Therapeutics, Inc. (LSTA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Lisata Therapeutics, Inc. (LSTA) Current Ratio vs. Peers

How is LSTA’s Current Ratio compared to its peers?

Lisata Therapeutics, Inc.’s Current Ratio is greater than Lixte Biotechnology Holdings, Inc. (5.13), greater than Histogen Inc. (4.05), greater than Imunon, Inc. (2.30), greater than Kineta, Inc. (0.14), less than Rezolute, Inc. (13.79), less than Cyteir Therapeutics, Inc. (21.89), greater than XOMA Corporation (7.52), greater than Protagenic Therapeutics, Inc. (1.80), greater than Tempest Therapeutics, Inc. (1.69), less than Pulmatrix, Inc. (19.40), greater than Onconova Therapeutics, Inc. (1.07), greater than Catalyst Biosciences, Inc. (3.72), greater than Bio-Path Holdings, Inc. (0.86), greater than Moleculin Biotech, Inc. (2.08), less than Alpine Immune Sciences, Inc. (9.56), less than AN2 Therapeutics, Inc. (9.75), greater than Ampio Pharmaceuticals, Inc. (2.41), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than Candel Therapeutics, Inc. (1.18),

Build a custom stock screener for Lisata Therapeutics, Inc. (LSTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lisata Therapeutics, Inc. (LSTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.